|
|
The 2nd Annual Australian Pharmacogenomics Summit is a unique conference dedicated to the field of pharmacogenomics. The summit will examine all the most pressing issues and prospects for the growth in this exciting sector. It will bring together national and international thought leaders, industry professionals and other key professionals under one roof to discuss the innovative industry trends and the applied strategies. The conference will provide an excellent opportunity to network with industry leaders and to exchange ideas and expertise. The forum will present advanced solutions to attain specific goals within the pharmacogenomics sector.
The 2nd Annual Australian Pharmacogenomics Summit will address the following topics:
- Cancer Pharmacogenomics - The Clinician's Perspective
- Pharmacogenetic Testing in Indigenous Communities
- Pharmacogenomics: Prediction of Treatment Response in Epilepsy
- Epigenetics - Relevant Considerations to Pharmacogenetics
- The Role of Immunogenetics in Drug Dependence
- The Pharmacogenetics of Methotrexate in Rheumatoid Arthritis
- Biobanks - Current status in Australia
- Pharmacogenomics in National Clinical Trials
- The Pharmacogenomics of Depression
- TPMT Genotyping Evaluation, Reporting & Interpretation
- The Consensus for Clinical Translation
Visitor Profile
The targeted visitors at the 2nd Annual Australian Pharmacogenomics Summit 2010 are:
- Researchers
- Manufacturers
- Heads of Pharamcy
- Medical Professionals
- Thought Leaders
- Biotech Professionals
- Academicians
Organizer
IIR Conferences
